Bruno Caramelli
Biographic Data
| ID | 7030594 |
|---|---|
| NAME | Bruno Caramelli |
| GIVEN NAMES | Bruno |
| FAMILY NAME | Caramelli |
| SIGNATURE | CARAMELLI B |
| AFFILIATIONS | Universidade de São Paulo |
| ORCID | 0000-0001-6718-8456 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Experiência de implantação de um comitê estadual de farmacovigilância na pandemia de covid-19
The pharmacovigilance committee played a significant role in the ESAVI surveillance system during the period of analysis by assisting in the evaluation of more complex cases. It shows potential to contribute positively to strengthening the immunization program, especially within the safe vaccination system framework
The “false-positive” conundrum
BACKGROUND: On 12 June 2020, Brazil reached the second position worldwide in the number of COVID-19 cases. Authorities increased the number of tests performed, including the identification of antibodies to SARS-CoV-2 (IgG, IgA, and IgM). There was an overflooding of the market with several tests, and the presence of possible false-positive results became a challenge. The purpose of this study was to describe the seroprevalence and immunoglobulin …
No prominent works on this page.
The “false-positive” conundrum
BACKGROUND: On 12 June 2020, Brazil reached the second position worldwide in the number of COVID-19 cases. Authorities increased the number of tests performed, including the identification of antibodies to SARS-CoV-2 (IgG, IgA, and IgM). There was an overflooding of the market with several tests, and the presence of possible false-positive results became a challenge. The purpose of this study was to describe the seroprevalence and immunoglobulin …
Experiência de implantação de um comitê estadual de farmacovigilância na pandemia de covid-19
The pharmacovigilance committee played a significant role in the ESAVI surveillance system during the period of analysis by assisting in the evaluation of more complex cases. It shows potential to contribute positively to strengthening the immunization program, especially within the safe vaccination system framework
Medicine (2 works) · 2019-20 coronavirus outbreak (1 work) · Antibody (1 work) · Asymptomatic (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 Clinical Research Studies (1 work) · Education during COVID-19 pandemic (1 work) · Healthcare Regulation (1 work) · Immunoassay (1 work) · Immunoglobulin A (1 work)